by Marc Puich | June 4, 2019
Success depends on defining and communicating broadly all facets of the therapy’s “real world” process requirements.
by Amy DuRoss | May 31, 2019
ASCO 2019 is here! With more cell and gene therapy advances in oncology, here are 10 important cell and gene therapy numbers we’re tracking in the fight against cancer.
by Vineti | May 30, 2019
In personalized therapies -- cell therapies, gene therapies, and neoantigen therapies -- a patient is not just the recipient of a drug product. The patient is the product.
by Amy DuRoss | May 22, 2019
One week to go! In the next seven days, those of us working in cell and gene therapy have a great chance to give input that will help our industry grow. See some areas of focus, with screenshots, in this post.
by Marc Puich | May 15, 2019
Standing up the ecosystem your therapy will rely on requires a solid operational plan for how will your therapy move between your key stakeholders.